Page 14 of presentation at the conference - in the last 6 quarters, there have been 2 quarters with identical revenue before a small jump in subsequent quarters.
I am pleased with reduced net cash outflow.
For reasons unknown to me, Morningstar are expecting only 20m revenue this year i.e. flat on Q1 but their valuation is $18. The net cash outflow expected by them for this year is $28m which I think we are on track for.
Overall, to me these are good results provided there is a pick up in revenue for the next quarter.
Mid term, the most important thing is to get reimbursement for out of hospital patients as that tripes current TAM.
- Forums
- ASX - By Stock
- AVH
- Ann: Preliminary Fiscal Second Quarter 2021 Results
Ann: Preliminary Fiscal Second Quarter 2021 Results, page-6
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.87 |
Change
0.105(3.80%) |
Mkt cap ! $195.4M |
Open | High | Low | Value | Volume |
$2.84 | $2.92 | $2.84 | $457.6K | 159.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $2.86 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.87 | 5985 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 870 | 2.850 |
6 | 9091 | 2.840 |
2 | 2600 | 2.830 |
1 | 167 | 2.820 |
1 | 5000 | 2.810 |
Price($) | Vol. | No. |
---|---|---|
2.860 | 619 | 3 |
2.870 | 5985 | 4 |
2.880 | 26395 | 5 |
2.890 | 550 | 1 |
2.900 | 20112 | 6 |
Last trade - 12.25pm 16/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online